Omega Diagnostics Group PLC
("Omega" or "the Company" or the "Group")
Announcement of Results
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it will release its results for the year ended 31 March 2019 on Monday 19 August 2019.
Contacts:
|
Omega Diagnostics Group PLC |
Tel: 01259 763 030 |
|
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive |
|
|
Kieron Harbinson, Group Finance Director |
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
|
Geoff Nash/James Thompson/ Hannah Boros (Corporate Finance) |
|
|
Camille Gochez (ECM) |
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or [email protected] |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Cawthorne |
Mob: 07584 391 303 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.